Autophagy is a prosurvival mechanism in cells expressing an autosomal dominant familial neurohypophyseal diabetes insipidus mutant vasopressin transgene

Autosomal dominant familial neurohypophyseal diabetes insipidus (adFNDI) is a progressive, inherited neurodegenerative disorder that presents as polydipsia and polyuria as a consequence of a loss of secretion of the antidiuretic hormone vasopressin (VP) from posterior pituitary nerve terminals. VP gene mutations cause adFNDI. Rats expressing an adFNDI VP transgene (Cys67stop) show a neuronal pathology characterized by autophagic structures in the cell body. adFNDI has thus been added to the list of protein aggregation diseases, along with Alzheimer's, Parkinson's and Huntington's, which are associated with autophagy, a bulk process that delivers regions of cytosol to lysosomes for degradation. However, the role of autophagy in these diseases is unclear. To address the relationships between mutant protein accumulation, autophagy, cell survival, and cell death, we have developed a novel and tractable in vitro system. We have constructed adenoviral vectors (Ads) that express structural genes encoding either the Cys67stop mutant protein (Ad‐VCAT‐Cys67stop) or an epitope‐tagged wild‐type VP precursor (Ad‐VCAT). After infection of mouse neuroblastoma Neuro2a cells, Ad‐VCAT encoded material enters neurite processes and accumulates in terminals, while the Cys67stop protein is confined to enlarged vesicles in the cell body. Similar to the intracellular derangements seen in the Cys67stop rats, these structures are of ER origin, and colocalize with markers of autophagy. Neither Ad‐VCAT‐Cys67stop nor Ad‐VCAT expression affected cell viability. However, inhibition of autophagy or lysosomal protein degradation, while having no effect on Ad‐VCAT‐expressing cells, significantly increased apoptotic cell death following Ad‐VCAT‐Cys67stop expression. These data suggest that activation of autophagy by the stress of the expression of an adFNDI mutant protein is a prosurvival mechanism.

[1]  A. Barrett,et al.  Interaction of human cathepsin D with the inhibitor pepstatin. , 1976, The Biochemical journal.

[2]  Rainer Duden,et al.  Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. , 2002, Human molecular genetics.

[3]  M. DiFiglia,et al.  Huntingtin Expression Stimulates Endosomal–Lysosomal Activity, Endosome Tubulation, and Autophagy , 2000, The Journal of Neuroscience.

[4]  P. Seglen,et al.  Inhibition of autophagic-lysosomal delivery and autophagic lactolysis by asparagine , 1991, The Journal of cell biology.

[5]  Y. Ohsumi,et al.  Ubiquitin and proteasomes: Molecular dissection of autophagy: two ubiquitin-like systems , 2001, Nature Reviews Molecular Cell Biology.

[6]  S. Waxman,et al.  Apoptosis of vasopressinergic hypothalamic neurons in chronic diabetes mellitus , 2004, Neurobiology of Disease.

[7]  C. Isidoro,et al.  Lysosomal proteases as potential targets for the induction of apoptotic cell death in human neuroblastomas , 2002, International journal of cancer.

[8]  J. Davies,et al.  Endoplasmic reticulum derangement in hypothalamic neurons of rats expressing a familial neurohypophyseal diabetes insipidus mutant vasopressin transgene , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Francesco Scaravilli,et al.  Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease , 2004, Nature Genetics.

[10]  J. Christensen,et al.  Autosomal dominant familial neurohypophyseal diabetes insipidus. , 2003, APMIS. Supplementum.

[11]  H. Gainer,et al.  Synthesis, transport, and release of posterior pituitary hormones. , 1980, Science.

[12]  L. Braverman,et al.  HEREDITARY IDIOPATHIC DIABETES INSIPIDUS. A CASE REPORT WITH AUTOPSY FINDINGS. , 1965, Annals of internal medicine.

[13]  D. Green,et al.  Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.

[14]  M. Kitamura,et al.  Construction of adenovirus vectors through Cre-lox recombination , 1997, Journal of virology.

[15]  E. Alvord,et al.  Heredtary and idiopathic types of diabetes insipidus. , 1967, Brain : a journal of neurology.

[16]  D. Murphy,et al.  Sorting of the vasopressin prohormone into the regulated secretory pathway , 2000, FEBS letters.

[17]  K. Kovacs,et al.  Hereditary diabetes insipidus: an immunohistochemical study of the hypothalamus and pituitary gland , 1991, Acta Neuropathologica.

[18]  M. Colombo,et al.  Induction of Autophagy Causes Dramatic Changes in the Subcellular Distribution of GFP‐Rab24 , 2002, Traffic.

[19]  H. Elsässer,et al.  Monodansylcadaverine (MDC) is a specific in vivo marker for autophagic vacuoles. , 1995, European journal of cell biology.

[20]  T. Yoshimori.  Autophagy: a regulated bulk degradation process inside cells. , 2004, Biochemical and biophysical research communications.

[21]  D. Sulzer,et al.  Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. , 2001, Human molecular genetics.

[22]  H. Kurokawa,et al.  Posterior lobe of the pituitary gland: correlation between signal intensity on T1-weighted MR images and vasopressin concentration. , 1998, Radiology.

[23]  P. Mathews,et al.  The Endosomal-Lysosomal System of Neurons in Alzheimer's Disease Pathogenesis: A Review , 2000, Neurochemical Research.

[24]  Y. Ohsumi,et al.  Beclin–phosphatidylinositol 3‐kinase complex functions at the trans‐Golgi network , 2001, EMBO reports.

[25]  J. Davies,et al.  Autophagy in Hypothalamic Neurones of Rats Expressing a Familial Neurohypophysial Diabetes Insipidus Transgene , 2002, Journal of neuroendocrinology.

[26]  R. Lockshin,et al.  Caspase-independent cell deaths. , 2002, Current opinion in cell biology.

[27]  J. Uney,et al.  Tetracycline‐Regulated Transgene Expression in Hippocampal Neurones Following Transfection with Adenoviral Vectors , 1997, Journal of neurochemistry.

[28]  Alexei Degterev,et al.  Diversity in the Mechanisms of Neuronal Cell Death , 2003, Neuron.

[29]  John T. Finn,et al.  Axonal Self-Destruction and Neurodegeneration , 2002, Science.

[30]  J. Jameson,et al.  A murine model of autosomal dominant neurohypophyseal diabetes insipidus reveals progressive loss of vasopressin-producing neurons. , 2003, The Journal of clinical investigation.

[31]  A. Cuervo.  Autophagy: in sickness and in health. , 2004, Trends in cell biology.

[32]  P. Codogno,et al.  Distinct Classes of Phosphatidylinositol 3′-Kinases Are Involved in Signaling Pathways That Control Macroautophagy in HT-29 Cells* , 2000, The Journal of Biological Chemistry.

[33]  H. Hibshoosh,et al.  Induction of autophagy and inhibition of tumorigenesis by beclin 1 , 1999, Nature.

[34]  S. Hsieh,et al.  Two cases of hereditary diabetes insipidus, with an autopsy finding in one. , 1984, Acta endocrinologica.

[35]  C. Isidoro,et al.  Endosomal-Lysosomal Proteolysis Mediates Death Signalling by TNFα, Not by Etoposide, in L929 Fibrosarcoma Cells: Evidence for an Active Role of Cathepsin D , 2002, Biological chemistry.

[36]  Y. Agid,et al.  Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. , 1997, Histology and histopathology.

[37]  James E. Goldman,et al.  Protection against Fatal Sindbis Virus Encephalitis by Beclin, a Novel Bcl-2-Interacting Protein , 1998, Journal of Virology.

[38]  P. Seglen,et al.  3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[39]  S. Arico,et al.  Diversity of signaling controls of macroautophagy in mammalian cells. , 2002, Cell structure and function.

[40]  H. Gainer,et al.  Gene regulation in the magnocellular hypothalamo-neurohypophysial system. , 2001, Physiological reviews.